ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,783, issued on June 24, was assigned to THORNHILL SCIENTIFIC INC. (North York, Canada).
"Identifying the vascularity of cerebral tissue in subjects using deoxyhemoglobin contrast" was invented by Jacob B. Schulman (Toronto), Kamil Uludag (Toronto), Joseph Arnold Fisher (Thornhill, Canada), David Mikulis (Oakville, Canada), Olivia Sobczyk (Etobicoke, Canada), Ece Su Sayin (Windsor, Canada), Julien Poublanc (Toronto) and James Duffin (Toronto).
According to the abstract* released by the U.S. Patent & Trademark Office: "Deoxyhemoglobin contrast has been used to locate arteries based on the earlier blood oxygen-level dependent (BOLD) signal arrival time, higher BOLD signal strength, ...